chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he had a cough; sore throat; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported for himself that, a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number was not reported, Expiry date: Unknown) via an unspecified route of administration on 25Apr2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient said that after the 1st dose he felt that he had a cough and sore throat on an unspecified date. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
developed an itchy left sided "mammary area" rash.; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 at 15:00 as a DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included food allergy and seasonal allergies  she stated, she has some allergies to food and seasonal allergies but doesn't specify both from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient developed an itchy left sided "mammary area" rash on 17Mar2021 at 23:00. Reporter stated, receiving the first Pfizer Covid vaccine dose on 17Mar2021 at 3 pm. At 11 pm that night, she developed an itchy left sided "mammary area" rash. She reported getting her injection in her left arm. She wanted to know if have any guidance on this. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
passed out; very bad infection from the Diverticulitis in the bowel; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out) and DIVERTICULITIS (very bad infection from the Diverticulitis in the bowel) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included LISINOPRIL for Blood pressure, POTASSIUM and OMEPRAZOLE for an unknown indication.    On 04-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced LOSS OF CONSCIOUSNESS (passed out) (seriousness criterion medically significant) and DIVERTICULITIS (very bad infection from the Diverticulitis in the bowel) (seriousness criterion medically significant). On 04-May-2021, LOSS OF CONSCIOUSNESS (passed out) had resolved. At the time of the report, DIVERTICULITIS (very bad infection from the Diverticulitis in the bowel) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, Blood potassium: Low. On 04-May-2021, Blood pressure measurement: Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Events included some other issues. Patient was treated with 2 unspecified antibiotics.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Hospitalized 2/21/2023. Died at the hospital 2/24/2023
Client is an 11 year old female who came in for her second dose. Client received a Pfizer 12+ dose. Client's Parent notified before leaving the clinic.
Left arm swelling , redness, and pain below LD. Keflex 250mg PO QIDx7days. Benadryl. Cellulitis
Asthma flare up symptoms. Menstrual cycle continuous, still ongoing as of 11/3/22. Heading to doctor appointment this afternoon, 11/3/22 at a local HCF.
This case was reported by a consumer via call center representative and described the occurrence of drug prescribing error in a adult female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included systemic lupus erythematosus. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced drug prescribing error and off label use. On an unknown date, the outcome of the drug prescribing error and off label use were unknown. Additional details were provided as follows: The age at vaccination was not applicable for the case. The patient reported that physician prescribed SHINGRIX even though she was 28 years old. The patient was not received the vaccine because she was unable to locate any at her local pharmacies but would receive it once it available again. The patient was lupus and was told she could not start methotrexate until she receive SHINGRIX. The patient had denied permission to contact their physician.
Patient received Moderna vaccine at 11:36am and Sx's began at 7:30pm. Patient reports hives on face and neck as well as swollen lips and eyes. patient also reported erythema over body. She dosed herself with 50 mg diphenhydramine and sx resolved within a half hour. Patient also reports that she had shellfish one hour prior to sx.
HEADACHE, FEVER T 102.8, CHILLS, NAUSEA/VOMITING, JOINT ACHES, LIGHT SENSITIVE Narrative: Employee had previously tested positive for COVID-19
Patient spiked a fever of 103.0; he will not eat any solids only formula; constantly sleepy; Sunday, 12/27/2009 a rash appeared all over his body (from head to toe). I was told to give him Tylenol and Motrin (alternate).
After receiving the vaccine the patient was asked to wait 15min during which time his wife alerted me that he had lost consciousness. I assesed the situation and instructed my technician to call 911. The patient was breathing normally but was very pale. I assisted him and he regained consciousness withing less than a minute. He stated that he had a phobia of needles.EMS arrived and checked vitals, the patient walked out of the store on his own.
Approximately 20 minutes after receiving the injection patient noted chest pain, itchy throat, throat swelling, rash on left arm, rash/swelling left neck, dizziness. Patient was taken to ER for evaluation.
First gave MENVEO then FLULAVAL in right arm then administered GARDASIL in left upper delt, pt asked to sit in chair was moving pt to chair he got pale and did not answer how he felt he passed out went to the floor with pt, slightly bumped head on wall. Pt came to in like 3 seconds called for help LPN and Dr came in helped pt to the table brought pt's mother into the room offered pt apple/orange juice. Pt refused. Color came back nicely. Dr came back in the room to re-examine pt with mom present. Redid BP was 108/70. Dr talked to pt and mother. Pt denied HA knows he bumped head a little sore. Held pt a little longer. Pt and mother went to check out. Did ask pt how he was feeling before he left. Pt denied any dizziness or headache as leaving. Did leave message today 10/12/18 with mom to see how pt is doing. Waiting a call back if any issues.
A patient called today to report tingling in her hands and arm that she thinks stems from a Shingles and Flu vaccine she received 3 days ago. She stated that the tingling started in her right hand yesterday and in her left hand today. The tingling in her left hand led to numbness in her left hand and arm. She received both vaccines in the left arm. The patient stated that she has a Doctors appointment on Oct 1 that she had scheduled prior to the vaccine. I instructed the patient to call the Doctor's office to see if they could see her before her appointment date.
Information has been received from a nurse referring to multiple unspecified patients of unknown age and gender. Information about patient's concurrent conditions and medical history was not reported. On unknown dates the patients were vaccinated with doses of GARDASIL 9 (dose and route not reported, lot number L020015 with expiration date 16-AUG-2017 and lot number L045711 with expiration date 08-MAY-2017) that were improperly stored (temperature: 12.3C and time frame: 4.5 hours). It was reported that there was a previous temperature excursion (9.6C for 2 hours). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because there was no consent for follow up.
Information has been received from a LVN concerning a 39 month old white female with NKDA or medical Hx who on 04/30/02 was vaccinated SQ in the RAT with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 08/24/04, the pt developed a breakthrough case of chicken pox. The pt had too many lesions to count which covered the trunk, back, and arms. She was noted to be afebrile. Unspecified medical attention was sought. A product quality complaint was not involved. Follow up information was received from the LVN who indicated that on 08/24/04 the pt has "too many to count macular rash on trunk, arms, and legs." The DX was varicella. The pt recovered on 08/30/04. No diagnostic lab tests were performed. Neither the pt nor her sibling had any adverse event following prior vaccinations. No further information is expected. The nurse also reported that the pt's brother developed chickenpox after therapy with varicella virus vaccine live (WAES 0409USA02169).
2 hours inconsolable screaming, pain, redness at injection site, went to urgent care and DX vaccine rx per mom. Treated with TYLENOL.
hives on lower back, left flank and less mild hive outbreak on stomach. Felt fatigued the next day. Hives were bothersome for 2 full days - They continue on 6 days later but not as bothersome and have not gotten worse. Also - bruising on tops of both hands developed next day.  Not painful - not an issue.  Went away within a few days.
Nauseousness & vertigo like symptoms occurred 2 days after 3rd vaccine. They lasted for 8 days. Disappeared for little over 2 wks & have come back. Am now on day 4 of same symptoms.
Pain in the back right side near kidney; This case was reported by a consumer via interactive digital media and described the occurrence of back pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2022, the patient received Shingrix. On 1st April 2022, less than a week after receiving Shingrix, the patient experienced back pain. On an unknown date, the outcome of the back pain was not recovered/not resolved.   It was unknown if the reporter considered the back pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 01-Apr-2022 Reporter's Comment: This case was reported by consumer via interactive digital media. The patient received Shingrix a week ago and now (at the time of reporting) had pain in the back right side near the kidney and wanted to know if this was normal.  Additional Supportive Information: The follow up would not possible as no contact details were available.
7/23/2022 starting at 1am-pain in the whole body especially in the chest area, 3am- fever of 37.5 degrees C. 7/24/2022 fatigue and chills
inflamed joints and lymph nodes. previous carpel tunnel syndrome that has been dormant for 10+ years became inflamed.
Seizure 11/30/09 Records received for DOS (hospitalization) 11/9/09-11/10/09. DC DX: Syncope and collapse. Pt. presented to ER c/o "passing out" and becoming stiff x2. grogginess, and sweatiness.  Neuro and cardiology consults obtained to r/o seizures vs syncope.
Chest tightness, lightheaded & nervousness; denies chest pain, SOB or difficulty breathing Vitals: 120/65, HR-80, pulse ox- 97% Client reports history of anxiety, PTSD; takes trazadone 50mg & Abilify 1.25mg nightly 0952- client reports feeling better, cleared by site lead
Tinnitus sound was doubled.  Screaming loud in the middle of the night.  Daytime sound enormously louder as well.  Previous tinnitus very light.  The increase has not diminished since Feb. 16. No effect on hearing.  Very debilitating.    Reaction after the first dose was minimal with no effect on tinnitus. (Received January 16 at .).
injection site bruised; injection site hard; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (injection site bruised) and INJECTION SITE INFLAMMATION (injection site hard) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE BRUISING (injection site bruised) and INJECTION SITE INFLAMMATION (injection site hard). At the time of the report, INJECTION SITE BRUISING (injection site bruised) and INJECTION SITE INFLAMMATION (injection site hard) outcome was unknown. Not Provided          No concomitant medications were provided. Treatment medications were unknown.
Had a deep sinus and head cold infection that start Nov 19th that continued into Dec.  Had running nose, cough, sore throat. Went to medical facility received antibiotics on Dec 4.  Dec 24th got sick again with running nose, chest congestion, cough, very bad sore throat went to another medical facility.
Client received dose #2.  Client stated after about 1 hour after she started developing severe pain in her left arm.  Client did take some Tylenol but the pain continued to escalade.  Client went to walk-in clinic who sent her over to the ER.  The only thing the ER doctor could find is that the injection could have been given to high in the deltoid.  Client also believes that the vaccine was administered to high and into the shoulder instead of the muscle.  Client states that her pain has gotten better but hasn't completely resolved.  She continues to exercise it on her own and plans to see an orthopedic doctor if the pain doesn't go away.
Patient received her second dose of Pfizer COVID-19 vaccine on 4/21/2021.   She has a purpura-like rash on extremities and trunk that started within days of receiving her second COVID-19 vaccination from Pfizer.  Assessment:   Purpura (HCC)  Thrombocytopenic purpura (HCC)  Plan:  CMP D-dimer, Quantitative CBC w/ diff, PT, PTT Referral to Hematology/Oncology
Dark and blistery rash; Dark and blistery rash; Rash on armpit and sides/Painful growing rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH VESICULAR (Dark and blistery rash), SKIN DISCOLOURATION (Dark and blistery rash) and RASH (Rash on armpit and sides/Painful growing rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, the patient experienced RASH VESICULAR (Dark and blistery rash), SKIN DISCOLOURATION (Dark and blistery rash) and RASH (Rash on armpit and sides/Painful growing rash). The patient was treated with KETOCONAZOLE at an unspecified dose and frequency and FLUCONAZOLE at an unspecified dose and frequency. At the time of the report, RASH VESICULAR (Dark and blistery rash), SKIN DISCOLOURATION (Dark and blistery rash) and RASH (Rash on armpit and sides/Painful growing rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Doctor told to patient it might be shingles or fungi infection; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event of vaccination site rash a causal relationship cannot be excluded. The event of rash was assessed as unrelated based on reporter causality.
COVID 19 Treatment; COVID 19 Treatment; Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 5 (booster), single (Lot number: Gh9693), in left arm and on 15Jun2023 as dose 6 (booster), single (Lot number: 616796) at the age of 65 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 13May2022 as dose 4 (booster), single (Lot number: Fn2908), in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 16Feb2021 as dose 1, single (Lot number: El3248), in left arm, on 09Mar2021 as dose 2, single (Lot number: En6199), in left arm and on 29Oct2021 as dose 3 (booster), single (Lot number: Fd0809), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 02Oct2023 as dose 7 (booster), single (Lot number: 8057658), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "gout" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "Allergy". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 02Oct2023, outcome "unknown", described as "Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19, interchange of vaccine products.
Vaccine Hurt as injected... Injection site red  Later that evening I discovered a painful welt .. The redness expanded all over my arm Alot of inflammation  99.5 Temp Chills  Steroids for 7 days
Lingered Swollen lymph glands/Throat glands have been swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lingered Swollen lymph glands/Throat glands have been swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lingered Swollen lymph glands/Throat glands have been swollen). At the time of the report, LYMPHADENOPATHY (Lingered Swollen lymph glands/Throat glands have been swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has stated the patient has experienced swollen throat glands, it was lingering but it was not severe. Patient has asked that patient should take the next dose or not. No Concomitant and treatment medication was provided by the Reporter.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Non Significant follow up appended to AER
ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA SHOCK, UNSPECIFIED 1/24/2022,  2/28/2022,  10/11/2022,  3/11/2023,  2/28/2023 -- RECURRENCE OF SAME SYMPTOMS
Initial and follow up information has been received from a registered nurse concerning an 19 year old white male patient. with environmental allergies and no illness at the time of vaccination, who on Aug 4 1992 previously reported as at 4 or 5 years of age was vaccinated with a second dose of mumps virus vaccine live (Jeryl Lynn) (lot 1811T). The patient had received the first dose of mumps virus vaccine live (Jeryl Lynn) on Aug 10 1986 (previously reported as at one year of age. The nurse reported that the patient was applying to become a firefighter and had a titer drawn which showed no immunity to mumps. The nurse did not have the reason why the child was given mono valent vaccines. Unspecified medical attention was sought. Follow up information reported that the patient was found to be non immun to mumps on Jul 27 2004 and Jul 30 2004. Laboratory evaluation revealed Jul 29 2004 it was reported that mumps AB IgG was 0.73 (reference range reported as 0.00 - 0.90 ISR) and the interpretation was negative or non immune, ON Jul 30 2004 laboratory testing showed mumps AB IgG was 0.65 and the interpretation was negative or non immune. On Aug 10 2004 the patient was vaccinated in the left arm with a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 647651/1144N) and then tested immune to mumps on Sept 02 2004. Laboratory evaluation collected on Aug 10 2004 and reported on Sept 03 2004 revealed mumps antibody IgG was 1.12 and the interpretation was positive or immune. No further information is available.
Pt received yellow fever injection @ 9:30, arm started itching around inject site, went to work, palms started itching and pt started feeling sick to stomach, went to ICC @ 10:25
Left calf abnormal leg pain on the back. Not going away. Urgent care didn?t see any signs of thrombosis, but the pain won?t go away.
No adverse event; Moderna 1st dose on 1-Jun-2021 Moderna 2nd dose on 10-Jul-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna 1st dose on 1-Jun-2021 Moderna 2nd dose on 10-Jul-2021) and NO ADVERSE EVENT (No adverse event) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna 1st dose on 1-Jun-2021 Moderna 2nd dose on 10-Jul-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna 1st dose on 1-Jun-2021 Moderna 2nd dose on 10-Jul-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna 1st dose on 1-Jun-2021 Moderna 2nd dose on 10-Jul-2021).    No concomitant medication were reported. No treatment information was provided by the reporter.   This case was linked to MOD-2023-720804 (Patient Link).
I started having breakthrough period bleeding overnight after my vaccine. I had a period less than a month ago and am on birth control pills. I have not missed any pills. I have had quite a bit of unusual spotting and it has not stopped since after my vaccine 5 days ago.
Chills, fever,  headache, fatigue, muscle aches, pain at the injection site